ReviewCureus2026
Outcomes of Peripheral Arterial Disease in Patients With Diabetic Foot Ulcers in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral arterial disease (PAD) compromises tissue perfusion in diabetic foot ulcers (DFUs) and is a principal driver of amputation and mortality. The prevalence, risk factor profile, and clinical consequences of PAD in DFU populations specific to low- and middle-income countries (LMICs) have not been systematically synthesized. The aim of this study was to synthesize the available evidence on the prevalence, determinants, and clinical outcomes of PAD among patients with DFUs in LMICs. We conducted a systematic review and meta-analysis of observational studies reporting PAD prevalence, associated risk factors, or clinical outcomes among DFU patients in LMICs. Electronic searches of PubMed, Web of Science, Scopus, and Lens.org were supplemented by manual reference screening. Random-effects meta-analysis with restricted maximum likelihood (REML) estimation was applied. Risk of bias was assessed using design-specific Joanna Briggs Institute critical appraisal tools. Publication bias was evaluated by Egger's regression, Kendall's tau, and Rosenthal's fail-safe N. Seventeen observational studies with 4,831 participants across nine LMICs were included. The pooled PAD prevalence was 43.00% (95% confidence interval (CI) 29.42%-57.74%; k = 11; N = 3,481; I² = 84.52%). Leave-one-out sensitivity analysis confirmed robustness of this estimate (range 39.37%-46.80%). Smoking was associated with more than twice the odds of PAD (pooled odds ratio (OR) 2.36; 95% CI 1.12-4.94; k = 6; I² = 61.9%), and hypertension nearly doubled the odds (pooled OR 1.84, 95% CI 1.20-2.82; k = 6; I² = 0.0%). PAD conferred a greater than fourfold increase in the odds of lower extremity amputation (pooled OR 4.14; 95% CI 2.24-7.63; k = 6; I² = 52.0%). Narrative evidence demonstrated reduced limb salvage, prolonged hospitalization, and excess mortality in PAD-affected cohorts. PAD is highly prevalent among DFU patients. Smoking and hypertension are consistent modifiable risk factors. These findings highlight the need for cardiovascular risk management within diabetic foot care in LMICs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.